Dug Recall and Product Correction for Adrenaline-Link

HPS Pharmacies wish to advise that Link Medical Products, in consultation with the Therapeutic Goods Administration (TGA), has issued a drug recall and product correction for their adrenaline pre-filled syringes, as follows:

Adrenaline-Link Pre-Filled Syringe
Adrenaline (epinephrine) acid tartrate 1:10 000 (1mg/10mL)
ARTG 210672

This market action follows a Product Defect Correction in 2024, related to reports of blocked syringe bores. Deaths have been reported in association with this issue.

The syringe barrel of the product has now been updated from a HYPAK syringe barrel to a HYLOK syringe barrel, eliminating the need for adaptors and enabling compatibility with additional connectors.

Recall: A recall is being undertaken for legacy HYPAK stock as the use of legacy stock with incompatible connectors or connectors without suitable adaptors may lead to blockages which can delay administration in emergency situations.

Affected batch: 0155765 (Exp: 31/05/2026) 

Please inspect your stock and quarantine all products from the affected batch. If HPS Pharmacies provide imprest management services to your facility, an HPS representative will inspect all stock stored in the designated imprest areas at the earliest opportunity. All affected products will be quarantined for return to the supplier, and HPS Pharmacies will arrange for replacement stock as soon as possible. An HPS Pharmacies staff member will contact senior medical and nursing staff if there is an immediate impact to your facility.

Retain this notice in a prominent position, including in other related business units for one month. Report any problems identified with medicines, vaccines or medical devices to the TGA.

Should you require further information regarding this matter, please contact Link Healthcare on (02) 8401 9777, or your pharmacist at HPS Pharmacies.

Download PDF